Author: et

Strengthening Hong Kong-Zhejiang ties

– Hong Kong Investment Promotion Conference – Zhejiang Ningbo Forum cum Ningbo-Hong Kong Economic Co-operation Forum was successfully held in Ningbo, attracting over 600 government and business leaders – Promoted Hong Kong’s role as superconnector and super value-adder to Zhejiang’s

More

Mooreast Holdings Announces Business Update

SINGAPORE, Apr 25, 2025 – (ACN Newswire via SeaPRwire.com) – The Board of Directors (“Board”) of Mooreast Holdings Ltd. (“Mooreast” or the “Company”), and together with its subsidiaries, the “Group”) wishes to provide an update on several recent developments:  Completion of

More

HighTide Therapeutics to Showcase New Analyses of Phase 2 MASH/T2DM Studies of Berberine Ursodeoxycholate (HTD1801) and Pre-Clinical Results of Rimtoregtide (HTD4010) in Presentations at EASL Congress 2025

HONG KONG, Apr 24, 2025 – (ACN Newswire via SeaPRwire.com) – HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for chronic liver and metabolic diseases, announced today that it will present

More

Coya Therapeutics Announces Positive Interim Results of an Investigator-Initiated Open Label Study with Low-Dose IL-2 and CTLA4-Ig Combination Treatment in Five Patients with Mild to Moderate Frontotemporal Dementia

– Results from the first patient cohort (N=5) of an open-label proof of concept academic study with low-dose IL-2 and CTLA4-Ig demonstrated a rapid and durable statistically significant increase in the number and suppressive function of Tregs compared to baseline

More